Omeros Corporation today announced two presentations that will be featured at the 2025 Tandem Meetings ? the Transplantation & Cellular Therapy Meetings of the American Society for Transplantation and ...

THB335 Phase 1 data support advancement into Phase 2 clinical trial in chronic spontaneous urticaria (CSU)Company initiating process to leverage ...

All treated AML patients in both the original and expansion cohorts through January 17, 2025 remain in complete remission. The original cohort of AML patients has reached a median CR of 23.3 months, ...

BJP returns to power after gap of 27 yrs, ending AAP's reign. Congress draws a blank for 3rd consecutive assembly poll.

Arcus Biosciences, Inc. , a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for patients with cancer, today announced that ...

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company dedicated to developing innovative therapies for unmet medical needs, today announced its collaboration with OnTargetx R&D Inc. to ...

Thank you for standing by, and welcome to Enterprise Products Partners L.P.’s Fourth Quarter 2024 Earnings Conference Call.

"The scale and scope of data to be presented at the ASCO GU meeting underscore the impact our whole-transcriptome-based Decipher tests are having in treating patients with urologic cancers, and how ...

This eBook celebrates the achievements of inspiring women in life sciences, highlighting their journeys, challenges and ...

Although no state improved in both math and reading on the NAEP, the Education Recovery Scorecard highlights the work of over ...